Resources Contact Us Home
Oligoadenylate synthetase (OAS)

Image Number 2 for United States Patent #8133710.

The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that have either enhanced cell permeability, reduced oxidative potential, improved antiviral activity, improved enzymatic activity, or absent enzymatic activity. The pharmaceutical compositions have improved drug properties and retain or have enhanced antiviral activity relative to their native forms. The pharmaceutical compositions further include chemically modified oligoadenylate synthetases, such chemical modifications being designed to increase serum stability and reduce immunogenicity in vivo. Such chemical modifications further increase drug stability and manufacturability in vitro. Compositions composed of more than ninety novel modifications are described. Also described are antibodies to polypeptides of the invention.

  Recently Added Patents
Downhole telemetry system
Defect detection system and method
Use of Lactobacillus for liver protection
2,2'-binaphthalene ester chiral dopants for cholesteric liquid crystal displays
Query optimization with awareness of limited resource usage
Systems and methods for universal enhanced log-in, identity document verification and dedicated survey participation
  Randomly Featured Patents
Grooming device
AM equalizer circuit for digital systems
Continuous flash butt-welding machine
Rectangular floating light
Food service package
Compounds and methods for treatment and diagnosis of mycobacterial infections
Transition strategy for the production of sticky polymers
Quantum dot manipulating method and quantum dot production/manipulation apparatus
Input device and methods and systems for same
Optical-electrical measuring method for determining cross-sectional dimensions